ReCode Therapeutics
PrivateLast Round
Grant
Sep 29, 2025
Est. Valuation
$372M
Total Funding Raised
$345M
Company Overview
ReCode Therapeutics is a biotechnology company specializing in targeted delivery technology that utilizes lipid nanoparticles to precisely administer genetic therapies for patients with rare diseases, addressing unmet medical needs and enhancing treatment options for life-limiting respiratory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReCode Therapeutics Comps
Public and private peers based on sector, stage, and business model.
ReCode Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 29, 2025 | ||||
| Grant | Nov 18, 2024 | ||||
| Series B Extension | Sep 19, 2023 | ||||
| Series B | Jan 10, 2023 | ||||
| Series B Extension | Jun 29, 2022 | ||||
Series B | Oct 21, 2021 |
Key People
Founding team and executive leadership
ReCode Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series B, Series B Extension |
| MPM Capital | Series A, Series B, Series B Extension |
| Bioluminescence Ventures | Series B Extension |
| Vida Ventures | Series A, Series B, Series B Extension |
| Osage University Partners | Series A, Series B, Series B Extension |
| OrbiMed | Series A, Series B, Series B Extension |
| Tekla Capital Management | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 29, 2025
Secured $3M in grant funding.
- Mar 25, 2025
Recognized by San Francisco Business Times and Silicon Valley Business Journal.
ReCode Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ReCode Therapeutics's valuation, stock price, and market status.
